Suppr超能文献

生物反馈治疗协同性排便障碍的长期疗效:随机对照试验。

Long-term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial.

机构信息

Department of Gastroenterology, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242-1009, USA.

出版信息

Am J Gastroenterol. 2010 Apr;105(4):890-6. doi: 10.1038/ajg.2010.53. Epub 2010 Feb 23.

Abstract

OBJECTIVES

Although biofeedback therapy is effective in the short-term management of dyssynergic defecation, its long-term efficacy is unknown. Our aim was to compare the 1-year outcome of biofeedback (manometric-assisted pelvic relaxation and simulated defecation training) with standard therapy (diet, exercise, laxatives) in patients who completed 3 months of either therapy.

METHODS

Stool diaries, visual analog scales (VASs), colonic transit, anorectal manometry, and balloon expulsion time were assessed at baseline, and at 1 year after each treatment. All subjects were seen at 3-month intervals and received reinforcement. Primary outcome measure (intention-to-treat analysis) was a change in the number of complete spontaneous bowel movements (CSBMs) per week. Secondary outcome measures included bowel symptoms, changes in dyssynergia, and anorectal function.

RESULTS

Of 44 eligible patients with dyssynergic defecation, 26 agreed to participate in the long-term study. All 13 subjects who received biofeedback, and 7 of 13 who received standard therapy, completed 1 year; 6 failed standard therapy. The number of CSBMs per week increased significantly (P<0.001) in the biofeedback group but not in the standard group. Dyssynergia pattern normalized (P<0.001), balloon expulsion time improved (P=0.0009), defecation index increased (P<0.001), and colonic transit time normalized (P=0.01) only in the biofeedback group.

CONCLUSIONS

Biofeedback therapy provided sustained improvement of bowel symptoms and anorectal function in constipated subjects with dyssynergic defecation, whereas standard therapy was largely ineffective.

摘要

目的

尽管生物反馈疗法在协同性排便障碍的短期治疗中有效,但长期疗效尚不清楚。我们的目的是比较生物反馈(测压辅助骨盆松弛和模拟排便训练)与标准治疗(饮食、运动、泻药)在完成 3 个月治疗的患者中 1 年的结果。

方法

在基线时以及每种治疗后 1 年评估粪便日记、视觉模拟量表(VAS)、结肠传输、肛门直肠测压和球囊排出时间。所有患者均在 3 个月间隔期就诊并接受强化治疗。主要疗效指标(意向治疗分析)是每周完全自发性排便次数(CSBMs)的变化。次要疗效指标包括肠道症状、协同性变化和肛门直肠功能。

结果

在 44 名符合条件的协同性排便障碍患者中,26 名同意参与长期研究。所有接受生物反馈的 13 名患者中,有 13 名和接受标准治疗的 7 名患者完成了 1 年,6 名患者未完成标准治疗。每周 CSBMs 的数量在生物反馈组显著增加(P<0.001),而在标准组则没有增加。协同性模式正常化(P<0.001)、球囊排出时间改善(P=0.0009)、排便指数增加(P<0.001)和结肠传输时间正常化(P=0.01)仅在生物反馈组中发生。

结论

生物反馈疗法为协同性排便障碍的便秘患者提供了持续的肠道症状和肛门直肠功能改善,而标准治疗则基本无效。

相似文献

5
10
Biofeedback for treatment of chronic idiopathic constipation in adults.生物反馈疗法治疗成人慢性特发性便秘
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD008486. doi: 10.1002/14651858.CD008486.pub2.

引用本文的文献

2
4
The Clinical Utility of Anorectal Manometry: A Review of Current Practices.肛门直肠测压的临床应用:当前实践综述
Gastro Hep Adv. 2024 Oct 10;4(2):100562. doi: 10.1016/j.gastha.2024.10.002. eCollection 2025.
5
Neurogastroenterology and motility disorders in patients with cirrhosis.肝硬化患者的神经胃肠病学与动力障碍
Hepatol Commun. 2025 Jan 7;9(1). doi: 10.1097/HC9.0000000000000622. eCollection 2025 Jan 1.

本文引用的文献

1
Dyssynergic defecation and biofeedback therapy.排便协同失调与生物反馈疗法
Gastroenterol Clin North Am. 2008 Sep;37(3):569-86, viii. doi: 10.1016/j.gtc.2008.06.011.
6
Comparison of rectoanal axial forces in health and functional defecatory disorders.健康人群与功能性排便障碍患者直肠肛门轴向力的比较。
Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1164-9. doi: 10.1152/ajpgi.00487.2005. Epub 2006 Feb 2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验